Massively Parallel DNA Sequencing Successfully Identifies New Causative Mutations in Deafness Genes in Patients with Cochlear Implantation and EAS

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Miyagawa, Maiko ^a   Nishio, Shin ya ^a   Ikeda, Takuo ^b   Fukushima, Kunihiro ^c   Usami, Shin ichi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Tsudumigaura Handicapped Children's Hospital   (Japan)

^c OKAYAMA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTG1 GENE; ARTICLE; AUDITORY STIMULATION; CLINICAL ARTICLE; COCHLEA PROSTHESIS; DNA SEQUENCE; ELECTRIC ACOUSTIC STIMULATION; EXON; FEMALE; FRAMESHIFT MUTATION; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC HETEROGENEITY; GJB2 GENE; HEARING IMPAIRMENT; HETEROZYGOSITY; HUMAN; JAPANESE; MALE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; MYO15A GENE; NONSENSE MUTATION; SLC26A4 GENE; STOP CODON; TECTA GENE; TMPRSS3 GENE;

ACOUSTIC STIMULATION; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COCHLEAR IMPLANTATION; DEAFNESS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GPI-LINKED PROTEINS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; MYOSINS; NEOPLASM PROTEINS; SEQUENCE ANALYSIS, DNA; SERINE ENDOPEPTIDASES; YOUNG ADULT;

EID: 84885156841     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075793     Document Type: Article

References (22)

1. Wilson BS, Dorman MF, (2008) Cochlear implants: a remarkable past and a brilliant future. Hear Res. 242: 3-21.
2. Eppsteiner RW, Shearer AE, Hildebrand MS, Deluca AP, Ji H, et al. (2012) Prediction of cochlear implant performance by genetic mutation: The spiral ganglion hypothesis. Hear Res. 292: 51-58.
3. Usami S, Nishio SY, Nagano M, Abe S, Yamaguchi T, (2012) Deafness Gene Study Consortium: Simultaneous screening of multiple mutations by invader assay improves molecular diagnosis of hereditary hearing loss: a multicenter study. PLoS One. 7: e31276.
4. Miyagawa M, Naito T, Nishio SY, Kamatani N, Usami SI (2013) Targeted exon sequencing successfully discovers rare causative genes and clarifies the molecular epidemiology of Japanese deafness patients. PLoS ONE. in press.
5. Zimmerman-Phillips S, Osberger MJ, Robbins AM (1997) Infant-Toddler: Meaningful Auditory Integration Scale (IT-MAIS) Sylmar, CA: Advanced Bionics Corporation.
6. Coninx F, Weichbold V, Tsiakpini L (2003) LittlEARS Auditory Questionnaire. Innsbruck, Austria: MED-EL.
7. Chang X, Wang K, (2012) wANNOVAR: annotating genetic variants for personal genomes via the web. J Med Genet. 49: 433-436.
8. Wang K, Li M, Hakonarson H, (2010) ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Research 38: e164.
9. Loman NJ, Misra RV, Dallman TJ, Constantinidou C, Gharbia SE, et al. (2012) Performance comparison of benchtop high-throughput sequencing platforms. Nat Biotechnol. 30: 434-439.
10. Liburd N, Ghosh M, Riazuddin S, Naz S, Khan S, et al. (2001) Novel mutations of MYO15A associated with profound deafness in consanguineous families and moderately severe hearing loss in a patient with Smith-Magenis syndrome. Hum Genet. 109: 535-541.
11. Wang A, Liang Y, Fridell RA, Probst FJ, Wilcox ER, et al. (1998) Association of unconventional myosin MYO15 mutations with human nonsyndromic deafness DFNB3. Science 280: 1447-1451.
12. Belyantseva IA, Boger ET, Friedman TB, (2003) Myosin XVa localizes to the tips of inner ear sensory cell stereocilia and is essential for staircase formation of the hair bundle. Proc Natl Acad Sci U S A. 100: 13958-13963.
13. Hildebrand MS, Morín M, Meyer NC, Mayo F, Modamio-Hoybjor S, et al. (2011) DFNA8/12 caused by TECTA mutations is the most identified subtype of nonsyndromic autosomal dominant hearing loss. Hum Mutat. 32: 825-834.
14. Mustapha M, Weil D, Chardenoux S, Elias S, El-Zir E, et al. (1999) An alpha-tectorin gene defect causes a newly identified autosomal recessive form of sensorineural pre-lingual non-syndromic deafness, DFNB21. Hum Mol Genet. 8: 409-412.
15. Guipponi M, Vuagniaux G, Wattenhofer M, Shibuya K, Vazquez M, et al. (2002) The transmembrane serine protease (TMPRSS3) mutated in deafness DFNB8/10 activates the epithelial sodium channel (ENaC) in vitro. Hum Mol Genet. 11: 2829-2836.
16. Weegerink NJ, Schraders M, Oostrik J, Huygen PL, Strom TM, et al. (2011) Genotype-phenotype correlation in DFNB8/10 families with TMPRSS3 mutations. J Assoc Res Otolaryngol. 12: 753-766.
17. Elbracht M, Senderek J, Eggermann T, Thürmer C, Park J, et al. (2007) Autosomal recessive post-lingual hearing loss (DFNB8): compound heterozygosity for two novel TMPRSS3 mutations in German siblings. J Med Genet. 44: e81.
18. Wattenhofer M, Sahin-Calapoglu N, Andreasen D, Kalay E, Caylan R, et al. (2005) A novel TMPRSS3 missense mutation in a DFNB8/10 family prevents proteolytic activation of the protein. Hum Genet. 117: 528-535.
19. Morín M, Bryan KE, Mayo-Merino F, Goodyear R, Mencía A, et al. (2009) In vivo and in vitro effects of two novel gamma-actin (ACTG1) mutations that cause DFNA20/26 hearing impairment. Hum Mol Genet. 18: 3075-3089.
20. von Ilberg CA, Baumann U, Kiefer J, Tillein J, Adunka OF. (2011) Electric-acoustic stimulation of the auditory system: a review of the first decade. Audiol Neurootol. Suppl. 2: 1-30.
21. Usami S, Miyagawa M, Suzuki N, Moteki H, Nishio S, et al. (2010) Genetic background of candidates for EAS (Electric-Acoustic Stimulation). Audiol Med. 8: 28-32.
22. Usami S, Miyagawa M, Nishio SY, Moteki H, Takumi Y, et al. (2012) Patients with CDH23 mutations and the 1555A>G mitochondrial mutation are good candidates for electric acoustic stimulation (EAS). Acta Otolaryngol. 132: 377-384.